PharmaShots | Incisive News in 3 Shots

Subscribe Now

Eledon

Eledon Reports Results of Tegoprubart in P-IIa Trial Demonstrated Safety, Target Engagement, and Biomarker Response for ALS

Eledon Reports Results of Tegoprubart in P-IIa Trial Demonstrated Safety, Target Engagement, and Biomarker Response for ALS

May 31, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us